ATE464883T1 - Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin - Google Patents

Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Info

Publication number
ATE464883T1
ATE464883T1 AT05759832T AT05759832T ATE464883T1 AT E464883 T1 ATE464883 T1 AT E464883T1 AT 05759832 T AT05759832 T AT 05759832T AT 05759832 T AT05759832 T AT 05759832T AT E464883 T1 ATE464883 T1 AT E464883T1
Authority
AT
Austria
Prior art keywords
formulation
retarded
flavor
covering
soluble cyclodextrin
Prior art date
Application number
AT05759832T
Other languages
English (en)
Inventor
Jennifer Hsing-Chung Chu
Dwayne Thomas Friesen
David Keith Lyon
Rodney James Ketner
Original Assignee
Bend Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bend Res Inc filed Critical Bend Res Inc
Application granted granted Critical
Publication of ATE464883T1 publication Critical patent/ATE464883T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
AT05759832T 2004-07-22 2005-07-11 Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin ATE464883T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59080304P 2004-07-22 2004-07-22
PCT/IB2005/002231 WO2006011051A1 (en) 2004-07-22 2005-07-11 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Publications (1)

Publication Number Publication Date
ATE464883T1 true ATE464883T1 (de) 2010-05-15

Family

ID=35094144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759832T ATE464883T1 (de) 2004-07-22 2005-07-11 Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Country Status (9)

Country Link
US (1) US20080075784A1 (de)
EP (1) EP1771161B1 (de)
JP (1) JP2008507504A (de)
AT (1) ATE464883T1 (de)
BR (1) BRPI0513455A (de)
CA (1) CA2574602A1 (de)
DE (1) DE602005020796D1 (de)
MX (1) MX2007000759A (de)
WO (1) WO2006011051A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP2708225B1 (de) 2004-04-23 2018-12-26 CyDex Pharmaceuticals, Inc. Sulfoalkylethercyclodextrin enthaltende DPI-Formulierung
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
KR101152886B1 (ko) 2005-10-26 2012-07-09 사이덱스 파마슈티칼스, 인크. 설포알킬 에테르 시클로덱스트린 조성물 및 그의 제조 방법
US7629331B2 (en) * 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20090239942A1 (en) * 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
JP2009091309A (ja) * 2007-10-10 2009-04-30 Japan Organo Co Ltd バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品
JPWO2009054432A1 (ja) * 2007-10-26 2011-03-03 第一三共株式会社 口腔内速崩壊性医薬組成物およびその製造方法
EP2219643B1 (de) 2007-11-15 2012-05-16 Novartis AG Anthelmintische paste mit praziquantel, einem makrolid-lacton, cyclodextrin und einem verdickungsmittel
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
NO2344129T3 (de) 2008-10-07 2018-07-21
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US20100273822A1 (en) * 2009-04-22 2010-10-28 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
US8545892B2 (en) * 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US8518448B2 (en) * 2009-06-26 2013-08-27 Robert Niichel Sustained release beads and suspensions including the same for sustained delivery of active ingredients
BR112012004692B8 (pt) 2009-09-04 2021-05-25 Mpex Pharmaceuticals Inc solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
CA2811202A1 (en) 2010-09-13 2012-03-22 Bev-Rx, Inc. Aqueous drug delivery system comprising off-flavor masking agent
BR112017014953A2 (pt) 2015-01-12 2018-03-13 Nano Pharmaceutical Laboratories Llc microglóbulos de liberação controlada em camadas e métodos para produção dos mesmos
CN107288680A (zh) * 2017-07-03 2017-10-24 安徽天顺环保设备股份有限公司 一种矿用泡沫除尘剂
EP4099977A1 (de) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. Einschichtige kautablette mit cetirizin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ES2121599T3 (es) * 1993-08-30 1998-12-01 Medichemie Ag Medicamento que contiene acido ursodeoxicolico en forma de administracion liquida.
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
PT1065936E (pt) * 1998-03-23 2009-09-24 Gen Mills Inc Encapsulação de componentes em produtos comestíveis
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US20030148996A1 (en) * 2000-03-31 2003-08-07 Joseph Rubinfeld Camptothecin complexes
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
KR101005648B1 (ko) * 2002-01-15 2011-01-05 유씨비 파쉼 소시에떼아노님 제형
MXPA04009617A (es) * 2002-04-04 2005-01-11 Pfizer Prod Inc Comprimido masticable con sabor agradable.

Also Published As

Publication number Publication date
JP2008507504A (ja) 2008-03-13
US20080075784A1 (en) 2008-03-27
BRPI0513455A (pt) 2008-05-06
EP1771161B1 (de) 2010-04-21
EP1771161A1 (de) 2007-04-11
DE602005020796D1 (de) 2010-06-02
CA2574602A1 (en) 2006-02-02
WO2006011051A1 (en) 2006-02-02
MX2007000759A (es) 2007-03-28

Similar Documents

Publication Publication Date Title
ATE464883T1 (de) Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
BR0015188A (pt) Composições farmacêuticas
EA200600877A1 (ru) Наночастицы для доставки лекарств
WO2007146248A3 (en) Stable laquinimod preparations
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
WO2005117895A8 (en) Compositions comprising meloxicam
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
DK1173176T3 (da) Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
CA2385755A1 (en) Prevention of colorectal cancer
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
NO20052408D0 (no) Farmasoytisk formulering av olanzapin
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties